Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
The American Journal of Bioethics : AJOB
|
October 18, 2025
The List to Nowhere: Last-Come, First-Served in High-Demand Psychiatric Services
Christopher Poppe, Dimitris Repantis
Current Topics in Behavioral Neurosciences
|
November 7, 2024
Ethical Aspects of Psychedelic-Assisted Treatments: An Overview
Christopher Poppe, Dimitris Repantis
The American Journal of Bioethics : AJOB
|
May 25, 2016
Securing Opportunities for the Disadvantaged, or Medicalization Through the Back Door?
Fred B Ketchum, Dimitris Repantis
AJOB Neuroscience
|
February 2, 2021
Memory, Authenticity, and Optogenethics
Jan Christoph Bublitz, Dimitris Repantis
Nature
|
August 8, 2023
Control side effects of the psychedelic renaissance
Christoph Bublitz, Nicolas Langlitz, Dimitris Repantis
Pharmacological Research
|
March 3, 2010
Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review
Dimitris Repantis, Oona Laisney, Isabella Heuser
JAMA Psychiatry
|
June 25, 2025
Offering Psychedelic Treatments Before Assisted Dying for Psychiatric Conditions
Christopher Poppe, Jan Christoph Bublitz, Dimitris Repantis
Brain and Behavior
|
June 17, 2026
Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study
Christopher Poppe, Liisa Lyck, Laura Bechtold, et al.
Pharmacological Research
|
April 27, 2010
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review
Dimitris Repantis, Peter Schlattmann, Oona Laisney, et al.
Psychological Medicine
|
September 29, 2025
Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review
Chiara Caporuscio, Christopher Poppe, Astrid Gieselmann, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
The American Journal of Bioethics : AJOB
|
October 18, 2025
The List to Nowhere: Last-Come, First-Served in High-Demand Psychiatric Services
Christopher Poppe, Dimitris Repantis
Current Topics in Behavioral Neurosciences
|
November 7, 2024
Ethical Aspects of Psychedelic-Assisted Treatments: An Overview
Christopher Poppe, Dimitris Repantis
The American Journal of Bioethics : AJOB
|
May 25, 2016
Securing Opportunities for the Disadvantaged, or Medicalization Through the Back Door?
Fred B Ketchum, Dimitris Repantis
AJOB Neuroscience
|
February 2, 2021
Memory, Authenticity, and Optogenethics
Jan Christoph Bublitz, Dimitris Repantis
Nature
|
August 8, 2023
Control side effects of the psychedelic renaissance
Christoph Bublitz, Nicolas Langlitz, Dimitris Repantis
Pharmacological Research
|
March 3, 2010
Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review
Dimitris Repantis, Oona Laisney, Isabella Heuser
JAMA Psychiatry
|
June 25, 2025
Offering Psychedelic Treatments Before Assisted Dying for Psychiatric Conditions
Christopher Poppe, Jan Christoph Bublitz, Dimitris Repantis
Brain and Behavior
|
June 17, 2026
Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study
Christopher Poppe, Liisa Lyck, Laura Bechtold, et al.
Pharmacological Research
|
April 27, 2010
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review
Dimitris Repantis, Peter Schlattmann, Oona Laisney, et al.
Psychological Medicine
|
September 29, 2025
Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review
Chiara Caporuscio, Christopher Poppe, Astrid Gieselmann, et al.
Page
of 3